US Patent Issued to Regeneron Pharmaceuticals on Aug. 5 for "Treatment of sepsis with PCSK9 and LDLR modulators" (New York Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,557, issued on Aug. 5, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Treatment of sepsis with PCSK9 and LDLR modulators" was invented by Julie Horowitz (Tarrytown, N.Y.), Luca Andrea Lotta (Tarrytown, N.Y.), Manuel Allen Revez Ferreira (Tarrytown, N.Y.), Amy Damask (Tarrytown, N.Y.), Charles Paulding (Tarrytown, N.Y.), Garen Manvelian (Tarrytown, N.Y.), Michael Cantor (Tarrytown, N.Y.) and Aris Baras (Tarrytown, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods of treating subjects having sepsis, SIRS, septic shock, and/or MODS, methods of identifying subjects having an increased risk of ...